The Dynamic Monitoring of Cerebrospinal Fluid ctDNA

NCT06315686 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: pemetrexed

Sponsor

Jiangsu Province Nanjing Brain Hospital